Deal to improve diagnostic services and patient outcomes across England through use of innovative technology
Royal Philips has announced a 10-year partnership with Rutherford Diagnostics utilising its innovative radiology technology and Rutherford’s clinical expertise to deliver advanced diagnostic services.
The agreement will see the two parties work in partnership to deliver advanced diagnostics services through five new diagnostics centres across the UK.
Under the terms of the agreement, which is built around a Managed Technology Service, Philips will deliver state-of-the-art imaging equipment provision; management and technology utilisation reporting; continuous training; and a research and innovation programme.
For Philips, a successful managed service uses technology as an enabler to drive improved clinical practices and patient outcomes through innovation and sustainability.
“Our mission at Philips is to improve people’s lives,” says Stephen McMillan, solutions lead for Philips in the UK.”
“We believe this partnership with Rutherford Diagnostics is an opportunity to deliver a truly-patient-centric diagnostic service with high levels of staff satisfaction.
“Philips already has a number of innovative managed service agreements with NHS partners here in the UK, so this is an exciting expansion of this service for us as we partner with our first private provider.”
Philips and Rutherford Diagnostics will help expand access to diagnostic services for local patients in a cost-effective way that supports the best-possible patient outcomes and experiences.
“Our focus is to change the current healthcare paradigm from a reactive model which responds to disease, to one that is pro-active and preventative with far-reaching, long-term benefits”, said Dr Steven Powell, chief executive of Rutherford Diagnostics.
“We required a strategic partner that would complement our diagnostic service offering with technological innovation, and Philips is closely aligned to our vision and can manage complexity while remaining flexible.”
The first three community diagnostic centres, the first in Liverpool, are due to go live in 2020, with the remaining two in 2021.